ES2195653T3 - Compuesto de s-oxido que disminuyen los lipidos. - Google Patents
Compuesto de s-oxido que disminuyen los lipidos.Info
- Publication number
- ES2195653T3 ES2195653T3 ES99964594T ES99964594T ES2195653T3 ES 2195653 T3 ES2195653 T3 ES 2195653T3 ES 99964594 T ES99964594 T ES 99964594T ES 99964594 T ES99964594 T ES 99964594T ES 2195653 T3 ES2195653 T3 ES 2195653T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- hydrogen
- formula
- lipides
- decrease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un compuesto de fórmula (I) **(Fórmula)** sus N - óxidos, sus formas estereoquímicamente isómeras, y sus sales de adición de ácido farmacéuticamente aceptables, en la cual n es 1 ó 2; R1 es hidrógeno, C1-6 alquilo o halo; R2 es hidrógeno o halo; R3 es C1-8 alquilo o C 3 - 6 cicloalquilo; Het es un radical de fórmula **(Fórmula)** en las cuales R4 es hidrógeno, C1-4 alquilo, trifluorometilo, amino o hidroxi; R5 es hidrógeno o C1-4 alquilo; R6 es hidrógeno o C1-4 alquilo; y - A - B - es un radical bivalente de fórmula - CH=CH - (b - 1) - N=CH - (b -2) - CH=N - (b - 3) en las cuales opcionalmente uno de los átomos de hidrógeno está reemplazado por C1-4 alquilo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98204410 | 1998-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2195653T3 true ES2195653T3 (es) | 2003-12-01 |
Family
ID=8234538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99964594T Expired - Lifetime ES2195653T3 (es) | 1998-12-22 | 1999-12-14 | Compuesto de s-oxido que disminuyen los lipidos. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6451802B1 (es) |
| EP (1) | EP1140917B1 (es) |
| JP (1) | JP2002533339A (es) |
| AR (1) | AR021969A1 (es) |
| AT (1) | ATE235487T1 (es) |
| AU (1) | AU761032B2 (es) |
| CA (1) | CA2355822A1 (es) |
| DE (1) | DE69906376T2 (es) |
| ES (1) | ES2195653T3 (es) |
| MY (1) | MY130851A (es) |
| NZ (1) | NZ512891A (es) |
| WO (1) | WO2000037463A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005230397B2 (en) * | 2004-04-09 | 2010-04-08 | Elanco Animal Health Ireland Limited | Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors |
| JP2008542255A (ja) * | 2005-05-27 | 2008-11-27 | ファイザー・プロダクツ・インク | 肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用 |
| MX2009012739A (es) * | 2007-05-25 | 2009-12-10 | Janssen Pharmaceutica Nv | Sintesis mejorada del metansulfonato(ester) de (2s-cis)-2-(bromometil)-2-(4-clorofenil)-1,3-dioxolan-4-metanol. |
| US9790104B2 (en) * | 2012-02-17 | 2017-10-17 | Hydrafact Limited | Water treatment |
| CN105980381A (zh) | 2013-11-08 | 2016-09-28 | 拜耳医药股份有限公司 | 取代的尿嘧啶及其用途 |
| CN111100112B (zh) * | 2018-10-29 | 2021-05-04 | 浙江京新药业股份有限公司 | 苯并噻吩衍生物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69519995T2 (de) | 1994-10-27 | 2001-08-23 | Janssen Pharmaceutica Nv | Apolipoprotein-b syntheseinhibitoren |
-
1999
- 1999-12-14 US US09/857,838 patent/US6451802B1/en not_active Expired - Fee Related
- 1999-12-14 AT AT99964594T patent/ATE235487T1/de not_active IP Right Cessation
- 1999-12-14 DE DE69906376T patent/DE69906376T2/de not_active Expired - Fee Related
- 1999-12-14 NZ NZ512891A patent/NZ512891A/xx unknown
- 1999-12-14 WO PCT/EP1999/010065 patent/WO2000037463A1/en not_active Ceased
- 1999-12-14 JP JP2000589534A patent/JP2002533339A/ja not_active Withdrawn
- 1999-12-14 AU AU30395/00A patent/AU761032B2/en not_active Ceased
- 1999-12-14 CA CA002355822A patent/CA2355822A1/en not_active Abandoned
- 1999-12-14 ES ES99964594T patent/ES2195653T3/es not_active Expired - Lifetime
- 1999-12-14 EP EP99964594A patent/EP1140917B1/en not_active Expired - Lifetime
- 1999-12-17 MY MYPI99005553A patent/MY130851A/en unknown
- 1999-12-21 AR ARP990106645A patent/AR021969A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002533339A (ja) | 2002-10-08 |
| CA2355822A1 (en) | 2000-06-29 |
| EP1140917A1 (en) | 2001-10-10 |
| AU3039500A (en) | 2000-07-12 |
| AU761032B2 (en) | 2003-05-29 |
| DE69906376T2 (de) | 2004-02-12 |
| WO2000037463A1 (en) | 2000-06-29 |
| ATE235487T1 (de) | 2003-04-15 |
| NZ512891A (en) | 2003-01-31 |
| MY130851A (en) | 2007-07-31 |
| DE69906376D1 (de) | 2003-04-30 |
| US6451802B1 (en) | 2002-09-17 |
| EP1140917B1 (en) | 2003-03-26 |
| AR021969A1 (es) | 2002-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4810382A1 (es) | Compuestos de indol agentes anti-inflamatorios/analgesicos | |
| AR037080A1 (es) | Compuestos utiles en el tratamiento de enfermedades inflamatorias,composiciones que los contienen, su uso en terapia, metodos de tratamiento, procesos de preparacion e intermediarios | |
| NO20025821L (no) | 2-aminokarbonyl-9H-purinderivater | |
| AR039689A1 (es) | Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso | |
| AR045037A1 (es) | Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion. | |
| DK0586490T3 (da) | Perhydroisoindolderivater, fremstilling af disse forbindelser og farmaceutiske sammensætninger indeholdende disse forbindelser | |
| HRP20000006B1 (en) | Gastrocinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives | |
| DE60317208D1 (de) | Pleuromutilinderivate als antimikrobielle mittel | |
| CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
| AR035205A1 (es) | Compuestos utiles en el tratamiento de enfermedades inflamatorias, proceso para su preparacion, intermediarios y composiciones farmaceuticas | |
| ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
| IL138068A (en) | Cyclic amino compounds and pharmaceutical compositions containing the same | |
| BR0210077A (pt) | Composto, seus sais, solvatos e ésteres hidrolisáveis farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar alfa | |
| CO6260099A2 (es) | Depsipeptidos ciclicos | |
| ES2195653T3 (es) | Compuesto de s-oxido que disminuyen los lipidos. | |
| DE69410956D1 (de) | Naphthylessigsäurederivate als PGEZ Agonisten und Antagonisten | |
| ES2422081T3 (es) | Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales | |
| DK0497121T3 (da) | Hidtil ukendte tetrazolderivater, fremgangsmåde til fremstilling af disse og anvendelsen af disse | |
| AR047486A1 (es) | Derivados de indolizina1,2,3,6,7,8, substituida, inhibidores de los fgfs, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
| HUP9801339A1 (hu) | Legyengült állapotok javítására alkalmas béta-adrenerg agonista hatású vegyületek | |
| CO4990971A1 (es) | Agentes terapeuticos selectivos de la mmp-3, especialmente con una buena selecti vidad con respecto a las mmp-1,2,9y/o 14 | |
| NZ505614A (en) | Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets | |
| AR028958A1 (es) | INHIBIDORES DE TRANSCRIPTASA INVERSA NO NUCLEoSIDOS | |
| DK0646578T3 (da) | Phenylcarboxamidisoxazoler og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmace | |
| AR057464A1 (es) | Procedimiento para la preparacion de derivados de sulfonamida |